| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 29 |
| 1 | CLOPIDOGREL BISULFATE | 29 |
| 2 | CLOPIDOGREL | 24 |
| 3 | WARFARIN | 24 |
| 4 | AMLODIPINE | 22 |
| 5 | ASPIRIN | 19 |
| 6 | ASPIRIN 325 MG | 19 |
| 7 | ASPIRIN 81 MG | 19 |
| 8 | PANTOPRAZOLE | 18 |
| 9 | LOSARTAN | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TENECTEPLASE | 2 | 0.0013 |
| 1 | PIRTOBRUTINIB | 1 | 0.0010 |
| 2 | CEFUROXIME | 9 | 0.0008 |
| 3 | TIOTROPIUM BROMIDE INHALATION SPRAY | 8 | 0.0007 |
| 4 | EDOXABAN TOSYLATE | 3 | 0.0004 |
| 5 | APIXABAN | 29 | 0.0004 |
| 6 | LEVOLEUCOVORIN INJECTION | 1 | 0.0003 |
| 7 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 7 | 0.0003 |
| 8 | CEFUROXIME AXETIL | 1 | 0.0003 |
| 9 | CLOPIDOGREL BISULFATE | 29 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 34 |
| 1 | Dihydropyridine Calcium Channel Blocker [EPC] | 23 |
| 2 | P2Y12 Platelet Inhibitor [EPC] | 23 |
| 3 | Calcium Channel Blocker [EPC] | 22 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 20 |
| 5 | Loop Diuretic [EPC] | 20 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 19 |
| 8 | Corticosteroid [EPC] | 12 |
| 9 | Proton Pump Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 1 | P2Y12 Platelet Inhibitor [EPC] | 23 | 0.0002 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 4 | Factor Xa Inhibitor [EPC] | 34 | 0.0001 |
| 5 | PCSK9 Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 23 | 0.0001 |
| 7 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 20 | 0.0001 |
| 9 | Nitrate Vasodilator [EPC] | 4 | 0.0000 |